News
Fermentalg, DSM sign DHA agreement
27 Sep 2018Fermentalg has announced the signing of an agreement with DSM Nutritional Products which will see the companies work together to develop and market high potency DHA products based on Fermentalg's ORIGINS DHA-550 product line.
Fermentalg has announced the signing of an agreement with DSM Nutritional Products in the field of high potency DHA products.
Under the terms of the five year agreement, Fermentalg and DSM will work together to develop and market high potency DHA products based on Fermentalg's ORIGINS DHA-550 product line.“This is groundbreaking news for Fermentalg”, said Philippe Lavielle, Fermentalg's CEO; “An agreement with the uncontested world leader in nutritional lipids clearly confirms the capability of Fermentalg's DHA platform. It will accelerate the penetration of ORIGINS DHA-550® into the dynamic and fast-growing high potency DHA omega-3 market, with the potential of elevating Fermentalg to the top tier of the world's largest algal DHA producers.”As part of this agreement, Fermentalg granted exclusivity to DSM for selling the products in certain market segments. Furthermore, the company will continue promoting its ORIGINS DHA product range through its established network of distributors in the USA and in Europe, notably in the growing markets of functional foods and nutritional supplements for brain, vision and cardiovascular health.